Pharmacy Management and Vaccines

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period. 1,2 A particular disease burden is present for Black Americans.

Vaccines

Vaccines Pharmacy Technician Immunization Immunity

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Pharmacy Times

JUNE 12, 2025

The introduction of the human papillomavirus (HPV) vaccine marked a major turning point, contributing to nearly a 50% reduction in incidence rates and a 70% decrease in mortality since the 1950s. It is more sensitive in identifying high-risk HPV types, enabling earlier detection of potential cancer risk.

Vaccines

Vaccines Pharmacy Technician Immunization Immunity

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Pharmacy Times

JUNE 13, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Chemotherapy

Chemotherapy Pharmacy Technician Immunization Immunity

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Trending Sources

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

OTC Case Studies: Summer Skin Care

Nitisinone Becomes First and Only FDA-Approved Treatment for HGA in Adults With AKU

ADA 2025: Insights into Diabetes, Obesity, and Pharmacist's Role in Advancing Care

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

ADA 2025: CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

New Online Competency Modules Standardize CPA Pharmacist Training at Academic Medical Center

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

5 Ways to Prepare for a Successful 2023 at Your Pharmacy

FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Pharmacy Star Ratings Changes Coming in 2023

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

Immunotherapy Takes the Lead in Advanced Cutaneous Malignancies

Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment

Overweight, Obesity Associated With Neurologic and Neuropsychiatric Symptoms in Post-COVID-19 Condition

New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic Care

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacies Need Strategies to Improve Health Care Access

Strep & Flu Testing at the Pharmacy

FDA Approves Datopotamab for Treatment of EGFR-Mutated Non-Small Cell Lung Cancer

What Pharmacists Should Know About Medicare Open Enrollment 2023

Stay Connected